Repligen Reports Fourth Quarter and Full Year 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
Repligen (RGEN) Tops Q4 EPS by 21c, Offers FY Guidance
February 24, 2021 7:38 AM ESTRepligen (NASDAQ: RGEN) reported Q4 EPS of $0.52, $0.21 better than the analyst estimate of $0.31. Revenue for the quarter came in at $108.6 million versus the consensus estimate of $93.88 million.
GUIDANCE:
Repligen sees FY2021 EPS of $1.86-$1.94, versus the consensus of $1.65. Repligen sees... More



